Drug therapy of hypertension: what we have, what we need, what we expect.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000959:Antihypertensive Agents / Q000145:classification / Q000592:standards / Q000627:therapeutic use*; D001158:Arteries / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002309:Cardiology; D003226:Congresses as Topic; D004219:District of Columbia; D004232:Diuretics / Q000627:therapeutic use; D011307:Drug Prescriptions; D004359:Drug Therapy, Combination; D005194:Family Practice; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008722:Methods; D009130:Muscle, Smooth / Q000187:drug effects; D008517:Phytotherapy; D010946:Plants, Medicinal; D011926:Rauwolfia / Q000627:therapeutic use; D012955:Societies, Medical; D013564:Sympathetic Nervous System / Q000187:drug effects; D014481:United States; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use; D014882:Water-Electrolyte Balance / Q000187:drug effects; D000092502:Renin Inhibitors
D000319:Adrenergic beta-Antagonists; D000804:Angiotensin II; D000959:Antihypertensive Agents; D002301:Cardiac Glycosides; D004232:Diuretics; D014665:Vasodilator Agents; D000092502:Renin Inhibitors